Work

Bat-26 is Associated with Clinical Stage and Lymph Node Status in Schistosomiasis Associated Bladder Cancer

Year: 2015
Type: article
Study design: Observational Study
Abstract: Background: Carcinoma of the urinary bladder is the most common malignancy in Egypt in which infection with Schistosoma haematobium is prevalent. This type of malignancy has different characteristics than that observed in the western world. We studied 5 microsatellite instability markers in exfoliated urinary samples from schistosomiasis associated bladder cancer cases and compared the results to the clinicopathological data of the patients. We also studied the sensitivity and specificity of these markers. Material and methods: The study included 32 histopathologically diagnosed BC patients and 11 age and sex matched normal controls. DNA was extracted from the exfoliated urinary cells and PCR was done and the product was separated by 12% PAGE. BAT-25, BAT-26, NR-21, NR-22 and NR-24 mutations were evaluated. Results: MSI in at least one marker was observed in 71.87% of BC cases. Mutations in BAT 25 (21.4%), BAT-26 (12.9%), NR-21 (58%), NR-22 (35.5%) were observed. No mutation was observed for NR-24 (0%). BAT 26 mutation was significantly associated with both tumor stage (P 0.03) and L.N metastasis (p 0.005). BAT25 was 21.4% sensitive and 100% specific. BAT26 mutation was 12.9% sensitive and 100% specific. NR21 was 58% sensitive and 100% specific. NR22 was 35.5% sensitive and 91% specific. NR24 was 0% sensitive and 100% specific for diagnosis. Conclusions: BAT26 mutation is significantly associated with clinical stage and lymph node metastasis in bladder cancer. All the tested markers showed high specificity. NR21 showed the highest sensitivity. More studies are needed to detect the prognostic significance of MSI in bladder cancer.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2147737437
FWCI:
Cites: 48
Cited by: 5
Related to: 10